IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.

Employees - 95, CEO - Oren Shuster, Sector - Healthcare, Country - IL, Market Cap -

Altman ZScore(max is 10): -15.78, Piotroski Score(max is 10): 2, Working Capital: $-12593151, Total Assets: $23684356, Retained Earnings: $-272186726, EBIT: -6658052, Total Liabilities: $28804756, Revenue: $44122337

- Current Price $ - Analyst Target Price $